NRXPW Insider Trading - NRx Pharmaceuticals, Inc.

Total Insiders

Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Se Højest rangerende aktier

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Se Højest rangerende aktier

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

NRx Pharmaceuticals, Inc. - Equity Warrant insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider	Aktier Ejet	Dele Justeret
Richard Ackerman President & CEO, Director, 10% Owner - [D] [O] [10%]	519.315	519.315
B Group, Inc. 10% Owner - [10%]	6.000.000	6.000.000
Richard Birdoff Director - [D]	0	0
BRAC Lending Group LLC 10% Owner - [10%]	590.435	590.435
Robert Besthof Chief Comm. & Patient Officer - [O]	23.710	2.371
Big Rock Partners Sponsor, LLC 10% Owner - [10%]	519.315	519.315
Alessandra Daigneault General Counsel & Secretary - [O]	31.584	3.158
Michael Fong Director - [D]	0	0

Insider	Aktier Ejet	Dele Justeret
Patrick John Flynn Director - [D]	1.750	175
Sharon Glied Director - [D]	13.168	1.317
Aaron Gorovitz Director - [D]	105.000	10.500
Chaim Hurvitz Director - [D]	2.214.793	221.479
Javitt Daniel C. 10% Owner - [10%]	9.634.793	963.479
Jonathan C Javitt Chairman and Chief Scientist, Director, 10% Owner - [D] [O] [10%]	1.516.834	1.516.834
Bennett Kim	0
Koenig Stuart F. Director - [D]	0	0
Steven Levine 10% Owner - [10%]	1.776.000	1.776.000

Insider	Aktier Ejet	Dele Justeret
Herbert Raymond McMaster Director - [D]	18.300	1.830
David M Nussbaum 10% Owner - [10%]	1.776.000	1.776.000
Polar Asset Management Partners Inc. 10% Owner - [10%]	488.036	488.036
Rex Albert G. Director - [D]	0	0
Troy T Taylor Director - [D]	0	0
Daniel Troy Director - [D]	43.093	4.309
Voorhees Seth Van CHIEF FINANCIAL OFFICER - [O]	16.337	1.634
Stephen H Willard CHIEF EXECUTIVE OFFICER, Director - [D] [O]	50.000	5.000
Lori Wittman CFO, Director - [D] [O]	0	0

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i NRXPW / NRx Pharmaceuticals, Inc. - Equity Warrant. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato	Insider	Rapporteret Aktier	Rapporteret Pris	Justeret Aktier	Justeret Pris	Omkostningsgrundlag	dage til Maks	Pris kl Maks	Maks Fortjeneste ($)	Maks. afkast (%)
2024-12-17	Javitt Jonathan C	40.000	1,1700	40.000	1,1700	46.800	28	5.1000	157.200	335,90
2023-08-30	Gorovitz Aaron	35.000	0,3199	3.500	3,1990	11.196
2023-08-30	Hurvitz Chaim	70.000	0,2875	7.000	2,8750	20.125
2023-08-23	Javitt Jonathan C	100.000	0,3300	10.000	3,3000	33.000
2023-08-22	Javitt Jonathan C	200.000	0,3220	20.000	3,2200	64.400
2022-12-16	Willard Stephen H	50.000	1,1700	5.000	11,7000	58.500
2022-11-28	Flynn Patrick John	2.500	1,2500	250	12,5000	3.125
2022-11-28	Flynn Patrick John	2.500	1,2400	250	12,4000	3.100
2022-11-28	Flynn Patrick John	1.750	1,2500	175	12,5000	2.188

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

NRXPW / NRx Pharmaceuticals, Inc. - Equity Warrant Insider Trades

Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i NRXPW / NRx Pharmaceuticals, Inc. - Equity Warrant. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato	Insider	Rapporteret Aktier	Rapporteret Pris	Justeret Aktier	Justeret Pris	Omkostningsgrundlag	dage til Min	Pris kl Min	Max tab Undgået ($)	Max tab Undgået (%)
2022-12-07	Javitt Jonathan C	400.000	1,0000	40.000	10,0000	400.000	292	0.2317	-390.732	-97,68
2022-07-29	Javitt Daniel C.	784.063	1,0094	78.406	10,0940	791.433
2022-06-07	Javitt Daniel C.	86.459	0,6461	8.646	6,4610	55.861
2022-06-06	Javitt Daniel C.	115.657	0,6653	11.566	6,6530	76.947
2022-06-03	Javitt Daniel C.	243.596	0,7024	24.360	7,0240	171.102
2021-09-15	Besthof Robert	40.000	11,7600	4.000	117,6000	470.400
2021-08-23	Daigneault Alessandra	33.715	13,1100	3.372	131,1000	442.004
2020-03-13	Polar Asset Management Partners Inc.	29.464	10,6000	29.464	10,6000	312.318
2018-11-20	ACKERMAN RICHARD	1.500.000		1.500.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil Dato	Handle Dato	Form	Insider	Ticker	Sikkerhedstitel	Kode	Direkte	Dyrke motion Pris	Enhed Pris	Enheder Ændret	Værdi Ændret (1K)	Tilbage Muligheder	Tilbage Aktier
2025-08-21		3	B Group, Inc. See Note 1	NRXP	Common Stock		I						3.000.000
2024-12-18	2024-12-17	4	Javitt Jonathan C	NRXP	Common Stock	P - Purchase	D		1,1700	40.000	47		84.634
2023-09-11	2023-08-30	4	Gorovitz Aaron By Spouse	NRXP	Common Stock, par value $0.001 per share	P - Purchase	I		0,3199	35.000	11		105.000
2023-09-11	2023-08-30	4	Hurvitz Chaim	NRXP	Common Stock, par value $0.001 per share	P - Purchase	D		0,2875	70.000	20		570.000
2023-08-24	2023-08-23	4	Javitt Jonathan C	NRXP	Common Stock	P - Purchase	D		0,3300	100.000	33		446.332
2023-08-23	2023-08-22	4	Javitt Jonathan C	NRXP	Common Stock	P - Purchase	D		0,3220	200.000	64		346.332
2023-02-14	2022-12-14	5	Javitt Jonathan C By Trust	NRXP	Common Stock, par value $0.001 per share	G - Gift	I			-300.000			14.468.329
2022-12-19	2022-12-16	4	Willard Stephen H	NRXP	Common Stock, par value $0.001 per share	P - Purchase	D		1,1700	50.000	58		50.000
2022-12-19	2022-12-16	4	VAN VOORHEES SETH	NRXP	Common Stock, par value $0.001 per share	P - Purchase	D		1,1000	30.000	33		46.337
2022-12-19	2022-11-25	4/A	VAN VOORHEES SETH	NRXP	Common Stock, par value $0.001 per share	P - Purchase	D		1,1100	7.021	8		16.337
2022-12-19	2022-11-25	4/A	VAN VOORHEES SETH	NRXP	Common Stock, par value $0.001 per share	P - Purchase	D		1,1000	600	1		9.316
2022-12-19	2022-11-25	4/A	VAN VOORHEES SETH	NRXP	Common Stock, par value $0.001 per share	P - Purchase	D		1,1200	8.716	10		8.716
2022-12-09	2022-12-07	4	Javitt Jonathan C By Trust	NRXP	Common Stock, par value $0.001 per share	S - Sale	I		1,0000	-400.000	-400		12.899.997
2022-12-01	2022-11-30	4	Javitt Daniel C. by Glytech LLC	NRXP	common stock	S - Sale	I		1,5046	-8.441	-13		9.634.793
2022-12-01	2022-11-29	4	Javitt Daniel C. by Glytech LLC	NRXP	common stock	S - Sale	I		1,5041	-13.730	-21		9.643.234
2022-11-29	2022-11-28	4	Flynn Patrick John	NRXP	Common Stock, par value $0.001 per share	P - Purchase	D		1,2500	1.750	2		1.750
2022-11-29	2022-11-28	4	Flynn Patrick John By Trust	NRXP	Common Stock, par value $0.001 per share	P - Purchase	I		1,2400	2.500	3		40.209
2022-11-29	2022-11-28	4	Flynn Patrick John By Trust	NRXP	Common Stock, par value $0.001 per share	P - Purchase	I		1,2500	2.500	3		37.709
2022-11-29	2022-11-28	4	Flynn Patrick John By Trust	NRXP	Common Stock, par value $0.001 per share	P - Purchase	I		1,2500	2.500	3		40.209
2022-11-29	2022-11-28	4	Flynn Patrick John By Trust	NRXP	Common Stock, par value $0.001 per share	P - Purchase	I		1,2500	2.500	3		37.709
2022-11-28	2022-11-25	4	VAN VOORHEES SETH Shares purchased though 401(k) plan	NRXP	Common Stock, par value $0.001 per share	P - Purchase	I		1,1100	7.021	8		16.377
2022-11-28	2022-11-25	4	VAN VOORHEES SETH Shares purchased though 401(k) plan	NRXP	Common Stock, par value $0.001 per share	P - Purchase	I		1,1000	600	1		9.316
2022-11-28	2022-11-25	4	VAN VOORHEES SETH Shares purchased though 401(k) plan	NRXP	Common Stock, par value $0.001 per share	P - Purchase	I		1,1200	8.716	10		8.716
2022-11-23	2022-11-18	4/A	Hurvitz Chaim	NRXP	Common Stock	P - Purchase	D		1,1000	40.408	44		500.000
2022-11-23	2022-11-17	4/A	Hurvitz Chaim	NRXP	Common Stock	P - Purchase	D		1,0800	171.780	186		459.592
2022-11-23	2022-11-16	4/A	Hurvitz Chaim	NRXP	Common Stock	P - Purchase	D		0,9900	287.812	285		287.812
2022-11-21	2022-11-18	4	Hurvitz Chaim	NRXP	Common Stock	P - Purchase	D		1,1000	40.408	44		500.000
2022-11-21	2022-11-17	4	Hurvitz Chaim	NRXP	Common Stock	P - Purchase	D		1,0800	171.780	186		459.592
2022-11-21	2022-11-16	4	Hurvitz Chaim	NRXP	Common Stock	P - Purchase	D		0,9900	287.812	285		287.812
2022-11-18	2022-11-17	4	Javitt Daniel C. by Glytech LLC	NRXP	common stock	S - Sale	I		1,0523	-33.018	-35		9.656.964
2022-11-18	2022-11-16	4	Javitt Daniel C. by Glytech LLC	NRXP	common stock	S - Sale	I		1,0200	-133.719	-136		9.689.982
2022-11-15	2022-11-11	4	Javitt Daniel C. by Glytech LLC	NRXP	common stock	S - Sale	I		1,0063	-49.200	-50		9.823.701
2022-08-02	2022-07-29	4	Javitt Daniel C. by Glytech LLC	NRXP	Common Stock	S - Sale	I		1,0094	-784.063	-791		9.872.901
2022-07-22		3	Willard Stephen H	NRXP	Restricted Common Stock, par value $0.001 per share		D						1.000.000
2022-07-05	2022-07-01	4	Javitt Daniel C. by Glytech LLC	NRXP	Common Stock	G - Gift	I			-2.000.000			10.656.964
2022-06-07	2022-06-07	4	Javitt Daniel C. by Glytech LLC	NRXP	Common Stock	S - Sale	I		0,6461	-86.459	-56		12.656.964
2022-06-07	2022-06-06	4	Javitt Daniel C. by Glytech LLC	NRXP	Common Stock	S - Sale	I		0,6653	-115.657	-77		12.743.423
2022-06-07	2022-06-03	4	Javitt Daniel C. by Glytech LLC	NRXP	Common Stock	S - Sale	I		0,7024	-243.596	-171		12.859.080
2022-06-02	2022-06-01	4/A	Javitt Jonathan C	NRXP	Common Stock	P - Purchase	D		0,5800	100.000	58		146.332
2022-06-02	2022-06-01	4	Javitt Jonathan C	NRXP	Common Stock	P - Purchase	D		58,0000	100.000	5.800		146.332
2022-03-10	2022-03-08	4	Besthof Robert	NRXP	Employee Stock Option	A - Award	D	2,61	2,6100	100.000	261	347.200
2021-11-02	2021-08-26	4	McMaster Herbert Raymond	NRXP	Restricted Stock Units	A - Award	D			10.424		10.424
2021-11-02	2021-08-26	4	McMaster Herbert Raymond	NRXP	Employee Stock Option (Right to buy)	C - Conversion	D	2,22	2,2200	-28.724	-64	16.362
2021-11-02	2021-08-26	4	McMaster Herbert Raymond	NRXP	Common Stock	M - Exercise	D		2,2200	18.300	41		18.300
2021-11-02	2021-09-02	4	Daigneault Alessandra	NRXP	Restricted Stock Units	A - Award	D			7.502		33.603
2021-11-02	2021-09-02	4	Daigneault Alessandra	NRXP	Restricted Stock Units	A - Award	D			10.496		26.101
2021-11-02	2021-09-02	4	Daigneault Alessandra	NRXP	Employee Stock Option (Right to buy)	C - Conversion	D	3,07	3,0700	-20.666	-63	28.934
2021-11-02	2021-09-02	4	Daigneault Alessandra	NRXP	Employee Stock Option (Right to buy)	C - Conversion	D	3,07	3,0700	-28.916	-89	71.924
2021-11-02	2021-09-02	4	Daigneault Alessandra	NRXP	Common Stock	M - Exercise	D		3,0700	13.164	40		31.584
2021-11-02	2021-09-02	4	Daigneault Alessandra	NRXP	Common Stock	M - Exercise	D		3,0700	18.420	57		18.420
2021-11-02	2021-08-23	4	Daigneault Alessandra	NRXP	Common Stock	S - Sale	D		13,1100	-33.715	-442		0
2021-11-02	2021-08-19	4	Daigneault Alessandra	NRXP	Restricted Stock Units	A - Award	D			15.605		15.605
2021-11-02	2021-08-19	4	Daigneault Alessandra	NRXP	Employee Stock Option (Right to buy)	C - Conversion	D	3,07	3,0700	-43.000	-132	100.840
2021-11-02	2021-08-19	4	Daigneault Alessandra	NRXP	Common Stock	M - Exercise	D		3,0700	27.395	84		33.715
2021-11-02	2021-07-16	4	Javitt Daniel C. By Glytech LLC	NRXP	Common Stock	G - Gift	I			-434.594			13.102.676
2021-11-02	2021-07-16	4	Javitt Daniel C. By Glytech LLC	NRXP	Common Stock	G - Gift	I			-434.594			13.102.676
2021-11-02	2021-09-15	4	Besthof Robert	NRXP	Common Stock	S - Sale	D		11,7600	-40.000	-470		23.710
2021-11-02	2021-08-16	4	Besthof Robert	NRXP	Restricted Stock Units	A - Award	D			36.290		36.290
2021-11-02	2021-08-16	4	Besthof Robert	NRXP	Employee Stock Option (Right to buy)	C - Conversion	D	0,20	0,2000	-100.000	-20	247.200
2021-11-02	2021-08-16	4	Besthof Robert	NRXP	Common Stock	M - Exercise	D		0,2000	63.710	13		63.710
2021-06-10	2021-05-24	4	Troy Daniel	NRXP	Employee Stock Option (Right to buy)	A - Award	D	2,18		65.437		65.437
2021-06-10	2021-05-24	4	Troy Daniel	NRXP	Common Stock	A - Award	D			43.093			43.093
2021-06-10	2021-05-24	4	Javitt Daniel C. By LLC	NRXP	Common Stock	A - Award	I			13.971.864			13.971.864
2021-06-10	2021-05-24	4	Javitt Jonathan C By Trust	NRXP	Common Stock	A - Award	I			1.422.000			1.422.000
2021-06-10	2021-05-24	4	Javitt Jonathan C By Trust	NRXP	Common Stock	A - Award	I			13.348.997			13.348.997
2021-06-10	2021-05-24	4	Javitt Jonathan C	NRXP	Common Stock	A - Award	D			46.332			46.332
2021-06-10	2021-05-24	4	Glied Sharon	NRXP	Employee Stock Option (Right to buy)	A - Award	D	0,21		65.437		65.437
2021-06-10	2021-05-24	4	Glied Sharon	NRXP	Common Stock	A - Award	I			13.168			13.168
2021-06-10	2021-05-24	4	Gorovitz Aaron By spouse	NRXP	Common Stock	A - Award	I			16.678			16.678
2021-06-10	2021-05-24	4	Gorovitz Aaron By Trust	NRXP	Common Stock	A - Award	I			8.336			8.336
2021-06-10	2021-05-24	4	Gorovitz Aaron By Trust	NRXP	Common Stock	A - Award	I			8.336			8.336
2021-06-10	2021-05-24	4	Gorovitz Aaron By Trust	NRXP	Common Stock	A - Award	I			8.336			8.336
2021-06-10	2021-05-24	4	Hurvitz Chaim	NRXP	Common Stock Warrant (Right to buy)	A - Award	I	1,53		218.423		218.423
2021-06-10	2021-05-24	4	Hurvitz Chaim	NRXP	Common Stock	A - Award	I			208.443			208.443
2021-06-10	2021-05-24	4	Hurvitz Chaim	NRXP	Common Stock	A - Award	I			1.436.350			1.436.350
2021-06-10	2021-05-24	4	Flynn Patrick John By Trust	NRXP	Common Stock Warrant (Right to buy)	A - Award	I	3,08		692.639		692.639
2021-06-10	2021-05-24	4	Flynn Patrick John By Trust	NRXP	Common Stock Warrant (Right to buy)	A - Award	I	3,08		692.639		692.639
2021-06-10	2021-05-24	4	Flynn Patrick John By Trust	NRXP	Common Stock	A - Award	I			35.209			35.209
2021-06-10	2021-05-24	4	Flynn Patrick John By Trust	NRXP	Common Stock	A - Award	I			35.209			35.209
2021-06-10	2021-05-24	4	Flynn Patrick John By LLC	NRXP	Common Stock	A - Award	I			362.332			362.332
2021-06-10	2021-05-24	4	Fricker William	NRXP	Employee Stock Option (Right to buy)	A - Award	D	3,08		99.200		198.400
2021-06-10	2021-05-24	4	Fricker William	NRXP	Employee Stock Option (Right to buy)	A - Award	D	3,08		99.200		198.400
2021-06-10	2021-05-24	4	Daigneault Alessandra	NRXP	Employee Stock Option (Right to buy)	A - Award	D	72,30		148.800		148.800
2021-06-10	2021-05-24	4	Daigneault Alessandra	NRXP	Employee Stock Option (Right to buy)	A - Award	D	3,08		49.600		49.600
2021-06-10	2021-05-24	4	Daigneault Alessandra	NRXP	Employee Stock Option (Right to buy)	A - Award	D	3,08		143.840		143.840
2021-06-10	2021-05-24	4	Daigneault Alessandra	NRXP	Common Stock	A - Award	D			6.320			6.320
2021-06-10	2021-05-24	4	Besthof Robert	NRXP	Employee Stock Option (Right to buy)	A - Award	D	0,21		347.200		347.200
2021-06-10	2021-05-24	4	Besthof Robert	NRXP	Employee Stock Option (Right to buy)	A - Award	D	3,08		347.200		347.200
2021-06-04	2021-05-24	4/A	BRAC Lending Group LLC	BRPA	Common Stock	D - Sale to Issuer	D			-869.565			590.435
2021-05-25	2021-05-24	4	Big Rock Partners Sponsor, LLC By A/Z Property Partners LLC	BRPA	Unit Purchase Option	P - Purchase	I	10,00	1,0000	100.000	100	100.000
2021-05-25	2021-05-24	4	Big Rock Partners Sponsor, LLC By Big Rock Partners Sponsor, LLC	BRPA	Rights, exchangeable for Common Stock	C - Conversion	I			-272.500		0
2021-05-25	2021-05-24	4	Big Rock Partners Sponsor, LLC By Big Rock Partners Sponsor, LLC	BRPA	Common Stock	C - Conversion	I			27.250			519.315
2021-05-25	2021-05-24	4	Big Rock Partners Sponsor, LLC By Big Rock Partners Sponsor, LLC	BRPA	Common Stock	D - Sale to Issuer	I			-5.435			492.065
2021-05-25	2021-05-24	4	BRAC Lending Group LLC	BRPA	Common Stock	D - Sale to Issuer	D			-869.565			562.435
2020-03-17	2020-03-13	4	Polar Asset Management Partners Inc.	BRPA	Common Stock, par value $0.001 per share	S - Sale	I		10,6000	-29.464	-312		488.036
2020-03-06		3	Polar Asset Management Partners Inc. See footnote 1	BRPA	Common Stock, par value $0.001 per share		I						1.035.000
2020-03-06		3	Polar Asset Management Partners Inc. See footnote 1	BRPA	Common Stock, par value $0.001 per share		I						1.035.000
2020-03-06		3	Polar Asset Management Partners Inc. See footnote 1	BRPA	Common Stock, par value $0.001 per share		I						1.035.000
2018-11-26		3	Levine Steven Held by BRAC Lending Group LLC	BRPA	Common Stock		I						3.138.000
2018-11-26		3	Levine Steven Held by BRAC Lending Group LLC	BRPA	Common Stock		I						3.138.000
2018-11-26		3	Levine Steven Held by EarlyBirdCapital, Inc.	BRPA	Common Stock		I						1.776.000
2018-11-26		3	Levine Steven Held by BRAC Lending Group LLC	BRPA	Common Stock		I						3.138.000
2018-11-26		3	Levine Steven Held by EarlyBirdCapital, Inc.	BRPA	Common Stock		I						1.776.000
2018-11-26		3	Levine Steven Held by EarlyBirdCapital, Inc.	BRPA	Common Stock		I						1.776.000
2018-11-26		3	Levine Steven Held by BRAC Lending Group LLC	BRPA	Common Stock		I						3.138.000
2018-11-26		3	Levine Steven Held by EarlyBirdCapital, Inc.	BRPA	Common Stock		I						1.776.000
2018-11-26		3	Levine Steven Held by EarlyBirdCapital, Inc.	BRPA	Common Stock		I						1.776.000
2018-11-26		3	Levine Steven Held by BRAC Lending Group LLC	BRPA	Common Stock		I						3.138.000
2018-11-20	2018-11-20	4	ACKERMAN RICHARD Big Rock Partners Sponsor, LLC	BRPA	Common Stock	S - Sale	I			-1.500.000			225.000
2017-12-04		3	BIRDOFF RICHARD	BRPAU	No securities are beneficially owned		D						0
2017-12-04		3	ACKERMAN RICHARD By Big Rock Partners Sponsor, LLC	BRPAU	Common Stock		I						2.225.000
2017-12-04		3	ACKERMAN RICHARD By Big Rock Partners Sponsor, LLC	BRPAU	Common Stock		I						3.700.000
2017-12-04		3	ACKERMAN RICHARD By Big Rock Partners Sponsor, LLC	BRPAU	Common Stock		I						3.700.000
2017-12-04		3	ACKERMAN RICHARD By Big Rock Partners Sponsor, LLC	BRPAU	Common Stock		I						2.225.000
2017-12-04		3	ACKERMAN RICHARD By Big Rock Partners Sponsor, LLC	BRPAU	Common Stock		I						3.700.000
2017-12-04		3	ACKERMAN RICHARD By Big Rock Partners Sponsor, LLC	BRPAU	Common Stock		I						2.225.000
2017-12-04		3	REX ALBERT G.	BRPAU	Common Stock		I						0
2017-12-04		3	FONG MICHAEL	BRPAU	Common Stock		I						0
2017-12-04		3	Wittman Lori	BRPAU	Common Stock		I						0
2017-12-04		3	Koenig Stuart F.	BRPAU	No securities are beneficially owned.		D						0
2017-12-04		3	Taylor Troy T	BRPAU	Common Stock		I						0
2017-12-04	2017-11-29	4	ACKERMAN RICHARD Big Rock Partners Sponsor, LLC	BRPAU	Warrant	P - Purchase	I	11,50		11.250		136.250
2017-12-04	2017-11-29	4	ACKERMAN RICHARD Big Rock Partners Sponsor, LLC	BRPAU	Right to receive common stock	P - Purchase	I			22.500		27.250
2017-12-04	2017-11-29	4	ACKERMAN RICHARD Big Rock Partners Sponsor, LLC	BRPAU	Common Stock	P - Purchase	I		10,0000	22.500	225		272.500

Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer

Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer

Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)

Konvertering af derivat

Salg eller overførsel af værdipapirer tilbage til virksomheden

Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet

Gave af værdipapirer af eller til insideren

Aktieswaps og lignende sikringstransaktioner

Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)

En transaktion rapporteret frivilligt på formular 4

Andet (ledsaget af en fodnote, der beskriver transaktionen)

NRXPW / NRx Pharmaceuticals, Inc. - Equity Warrant - Insider Trading and Ownership Report - SEC Form 3, 4, 5